UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 12b-25

 

NOTIFICATION OF LATE FILING

 

(Check one): x Form 10-K   ¨ Form 20-F   ¨ Form 11-K o Form 10-Q   o Form N-SAR ¨ Form N-CSR

 

For Period Ended:   December 31 2022 

 

oTransition Report on Form 10-K

oTransition Report on Form 20-F

oTransition Report on Form 11-K

oTransition Report on Form 10-Q

oTransition Report on Form N-SAR

 

For the Transition Period Ended:

 

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

 

If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:

 

PART I -- REGISTRANT INFORMATION

         

Full Name of Registrant

  

Bio-En Holdings Corp.

 

Former Name if Applicable

                                 

Address of Principal Executive Office (Street and Number)

      

1 County Road, Unit B6, Secaucus, New Jersey NJ 07094

 

 

 

 

 

 

PART II -- RULES 12b-25(b) AND (c)

 

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

 

 x (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
     
 x (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     
  (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

  

PART III -- NARRATIVE

 

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

 

Bio-En Holdings Corp.

the “Registrant”) was unable, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the period ended December 31, 2022 (the “Annual Report”) by the March 31, 2023 filing date applicable to smaller reporting companies due to a delay experienced by the Registrant  in  completing  its  financial  statements  and  other  disclosures  in  the  Annual Report.  As  a  result,  the  Registrant  is  still  in  the  process  of  compiling required information to complete the Annual Report and its independent registered public accounting firm requires additional time to complete its audit of financial statements for the year ended December 31, 2022 to be incorporated in the Annual Report. The Registrant anticipates that it will file the Annual Report no later than the fifteenth

calendar day following the prescribed filing date. 

 

PART IV -- OTHER INFORMATION

 

(1) Name and telephone number of person to contact in regard to this notification

 

 Barry Adika (212) 255  -  2144
 (Name)   (Area Code)   (Telephone Number)

 

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). Yes x Noo

 

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? 
Yes o  No x

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

 

 

 

 

 Bio-En Holdings Corp  

 

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Dated:  March 29, 2023 By:   /s/
  Barry Adika 
  President

 

 

 

 

 

 

Bio En (CE) (USOTC:BENH)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Bio En (CE) Charts.
Bio En (CE) (USOTC:BENH)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Bio En (CE) Charts.